Signum Surgical Appoints Carol Burns as CEO

Signum Surgical Appoints Carol Burns as CEO

News Release – 12 March 2025, Galway, Ireland | Signum Surgical, (‘Signum’ or ‘the Company’) the medical technology company developing innovative solutions to treat colorectal diseases, is pleased to announce the appointment of Ms. Carol Burns as Chief Executive Officer. Ms. Burns’ appointment is a pivotal milestone for Signum, as the Company initiates commercialization of BioHealx®, a first-of-its-kind medical device for the treatment of anal fistula, … Continue reading Signum Surgical Appoints Carol Burns as CEO

Lingraphica

Lingraphica Announces Leadership Transition: Kevin Self to Succeed Andrew Gomory as CEO

Press Release – PRINCETON, N.J. – Lingraphica, a leader in augmentative and alternative communication (AAC) devices, announced a significant leadership transition. Current Chief Operating Officer Kevin Self has assumed the role of Chief Executive Officer effective January 1, 2025. He succeeds Andrew Gomory, a visionary leader who has retired after over two decades of driving the company’s innovation and expanding its industry presence, while continuing … Continue reading Lingraphica Announces Leadership Transition: Kevin Self to Succeed Andrew Gomory as CEO

Topcon Healthcare

Jacques Gilbert Appointed Chief Strategy and Business Development Officer at Topcon Healthcare, Inc.

Press Release – December 19, 2024 – OAKLAND, N.J. – Topcon Healthcare, Inc., a leading provider of medical devices and digital healthcare solutions, is pleased to announce the appointment of Jacques Gilbert as Chief Strategy and Business Development Officer. In this pivotal role, Jacques will lead the development and execution of Topcon Healthcare’s business strategy, focusing on the company’s groundbreaking Healthcare from the Eye™ initiative—a connected care ecosystem using oculomics, … Continue reading Jacques Gilbert Appointed Chief Strategy and Business Development Officer at Topcon Healthcare, Inc.

dexcom

Dexcom Launches the First Generative AI Platform in Glucose Biosensing

Press Release – December 17, 2024 – SAN DIEGO – DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first CGM manufacturer to integrate GenAI into glucose biosensing technology.1 The new Dexcom GenAI platform will analyze individual health data patterns to reveal a direct association between lifestyle choices and glucose levels while providing … Continue reading Dexcom Launches the First Generative AI Platform in Glucose Biosensing

Samsara Vision

Samsara Vision Promotes Jason Herod to Chief Commercial Officer

FAR HILLS, N.J. – Samsara Vision today announced that Jason Herod, Vice President Commercial, International Markets, is promoted to Chief Commercial Officer, effective August 15, 2024. Samsara Vision is a privately held specialty medical device company focused on intraocular ophthalmic devices that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. Jason Herod joined Samsara Vision in August 2021 … Continue reading Samsara Vision Promotes Jason Herod to Chief Commercial Officer